ClinicalTrials.Veeva

Menu

Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance (GFR-ARC)

A

Assistance Publique - Hôpitaux de Paris

Status

Enrolling

Conditions

Critically Ill
Augmented Renal Clearance

Treatments

Drug: Iohexol

Study type

Interventional

Funder types

Other

Identifiers

NCT04776486
APHP190414
2019-A00654-53 (Other Identifier)

Details and patient eligibility

About

Evaluation of glomerular filtration rate using iohexol plasma clearance in critically ill patients with augmented renal creatinine clearance

Full description

Single center study in ICU patients with augmented renal clearance comparing glomerular filtration rate (GFR) as measured by iohexol plasma clearance to that measured by creatinine clearance. Primary objective is to compare the GFR estimates made by iohexol plasma clearance (as reference method) and creatinine clearance using Bland-Altman method.

Secondary objective are to compare GFR as measured by iohexol plasma clearance to that calculated with the most commonly used renal clearance estimating formulas (Cockcroft and Gault, MDRD and CKD-EPI ), evaluate clinical determinant of the observed differences and evaluate determinants of extracellular volume.

Enrollment

90 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ICU patient
  • 24h Creatinine clearance >130ml/min/1.73m2
  • Urinary catheterization
  • Affiliation to a social security scheme

Exclusion criteria

  • Pregnancy
  • CT-scan with contrast media infusion the day of inclusion
  • Documented allergy to contrast media
  • Patient under guardianship / curatorship
  • Patient benefiting from the "State Medical Assistance"

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

90 participants in 1 patient group

Critically ill patients with augmented renal clearance
Experimental group
Description:
ICU patients with estimated renal clearance over 130ml/min/1.73m2
Treatment:
Drug: Iohexol

Trial contacts and locations

1

Loading...

Central trial contact

Magalie Collet, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems